completed

To determine the feasibility of a controlled trial examining the efficacy and safety of novel oral anticoagulants (NOACs), compared with aspirin, for stroke prevention in patients with high-risk atrial fibrillation (AF) and previous intracerebral hemorrhage (ICH).

The primary outcome is composite of ischemic stroke and recurrent ICH.

Download Presentation PDF
Study Type

Interventional - Drug

Study Design

Open-label, multicentre phase II randomized pilot study

NO. of Countries

1

NO. of Sites

9

NO. of Participants

30

Study Period

2017-2019

Sponsor

PHRI

Canadian Stroke Prevention Intervention Network (C-SPIN)

PHRI

Heart & Stroke Foundation

Back To Top